125 related articles for article (PubMed ID: 17251216)
21. N-acetylcysteine as a preventive measure for acute renal failure: a plea for more accurate detection of renal function in critically ill patients.
Schultz MJ
Crit Care Med; 2007 Jun; 35(6):1633-4. PubMed ID: 17522549
[No Abstract] [Full Text] [Related]
22. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment.
Sheikh-Hamad D; Timmins K; Jalali Z
J Am Soc Nephrol; 1997 Oct; 8(10):1640-4. PubMed ID: 9335396
[TBL] [Abstract][Full Text] [Related]
23. N-Acetyl Cysteine Therapy Does Not Prevent Renal Failure in High-Risk Patients Undergoing Open-Heart Surgery.
Rababa'h AM; Deo SV; Altarabsheh SE; De Caro J; Tarboush NA; Alzoubi KH; Ababneh M; McConnell BK; Markowitz AH; Park SJ
Heart Surg Forum; 2016 Feb; 19(1):E16-22. PubMed ID: 26913679
[TBL] [Abstract][Full Text] [Related]
24. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
Briguori C; Quintavalle C; De Micco F; Condorelli G
Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
[TBL] [Abstract][Full Text] [Related]
25. Bridging Translation by Improving Preclinical Study Design in AKI.
de Caestecker M; Humphreys BD; Liu KD; Fissell WH; Cerda J; Nolin TD; Askenazi D; Mour G; Harrell FE; Pullen N; Okusa MD; Faubel S;
J Am Soc Nephrol; 2015 Dec; 26(12):2905-16. PubMed ID: 26538634
[TBL] [Abstract][Full Text] [Related]
26. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
[TBL] [Abstract][Full Text] [Related]
27. Preconditioning renoprotective effect of isoflurane in a rat model of virtual renal transplant.
Su MW; Chang SS; Chen CH; Huang CC; Chang SW; Tsai YC; Lam CF
J Surg Res; 2014 Jun; 189(1):135-42. PubMed ID: 24674838
[TBL] [Abstract][Full Text] [Related]
28. Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants.
Heidari R; Taheri V; Rahimi HR; Shirazi Yeganeh B; Niknahad H; Najibi A
Ren Fail; 2016; 38(1):137-41. PubMed ID: 26479898
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based practice for the use of N-acetylcysteine.
Marthaler MT; Keresztes PA
Dimens Crit Care Nurs; 2004; 23(6):270-3. PubMed ID: 15586041
[TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Barr LF; Kolodner K
Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
[TBL] [Abstract][Full Text] [Related]
31. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
Billinger M; Hess OM; Meier B
Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
[No Abstract] [Full Text] [Related]
32. Acetylcysteine and renal function following coronary angiographic procedures.
Bagshaw SM; Culleton BF
JAMA; 2003 Jun; 289(21):2795; author reply 2796. PubMed ID: 12783908
[No Abstract] [Full Text] [Related]
33. Acetylcysteine and renal function following coronary angiographic procedures.
Balderramo DC
JAMA; 2003 Jun; 289(21):2795-6; author reply 2796. PubMed ID: 12783907
[No Abstract] [Full Text] [Related]
34. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
36. A drug to prevent renal failure?
Kellum JA
Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
[No Abstract] [Full Text] [Related]
37. Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
Kefer JM; Hanet CE; Boitte S; Wilmotte L; De Kock M
Acta Cardiol; 2003 Dec; 58(6):555-60. PubMed ID: 14713182
[TBL] [Abstract][Full Text] [Related]
38. Prevention of acute renal failure with N-acetylcysteine--enough is enough?
Koller H; Rosenkranz AR
Kidney Int; 2004 Sep; 66(3):1292-3; author reply 1292-3. PubMed ID: 15327439
[No Abstract] [Full Text] [Related]
39. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant treatment and outcome of Cortinarius orellanus poisoning: a case series.
Grebe SO; Langenbeck M; Schaper A; Berndt S; Aresmouk D; Herget-Rosenthal S
Ren Fail; 2013; 35(10):1436-9. PubMed ID: 23968303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
